000845495 001__ 845495
000845495 005__ 20210129233443.0
000845495 0247_ $$2doi$$a10.23736/S1824-4785.18.03090-X
000845495 0247_ $$2pmid$$apmid:29696947
000845495 0247_ $$2WOS$$aWOS:000445240400005
000845495 037__ $$aFZJ-2018-02729
000845495 082__ $$a570
000845495 1001_ $$0P:(DE-HGF)0$$aSuchorska, B.$$b0$$eCorresponding author
000845495 245__ $$aThe role of amino acid PET in the light of the new WHO classification 2016 for brain tumors
000845495 260__ $$aTorino$$bEd. Minerva Medica$$c2018
000845495 3367_ $$2DRIVER$$aarticle
000845495 3367_ $$2DataCite$$aOutput Types/Journal article
000845495 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1536757454_4839
000845495 3367_ $$2BibTeX$$aARTICLE
000845495 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000845495 3367_ $$00$$2EndNote$$aJournal Article
000845495 520__ $$aSince its introduction in 2016, the revision of the World Health Organization (WHO) classification of central nervous system tumors has alreadychanged the diagnostic and therapeutic approach in glial tumors. Blurring the lines between entities formerly labelled as “high-grade” or “lowgrade”,molecular markers define distinct biological subtypes with different clinical course. This new classification raises the demand for noninvasiveimaging methods focusing on depicting metabolic processes. We performed a review of current literature on the use of amino-acid PET(AA-PET) for obtaining diagnostic or prognostic information on glioma in the setting of the current WHO 2016 classification. So far, only a fewstudies have focused on combining molecular genetic information and metabolic imaging using AA-PET. The current review summarizes theinformation available on “molecular grading” as well as prognostic information obtained from AA-PET and delivers an insight into a possibleinterrelation between metabolic imaging and glioma genetics. Within the framework of molecular characterization of gliomas, metabolic imagingusing AA-PET is a promising tool for non-invasive characterization of molecular features and to provide additional prognostic information.Further studies incorporating molecular and metabolic features are necessary to improve the explanatory power of AA-PET in glial tumors
000845495 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000845495 7001_ $$0P:(DE-HGF)0$$aAlbert, N. L.$$b1
000845495 7001_ $$0P:(DE-HGF)0$$aBauer, E. K.$$b2
000845495 7001_ $$0P:(DE-HGF)0$$aTonn, J. C.$$b3
000845495 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, N.$$b4
000845495 773__ $$0PERI:(DE-600)2083933-9$$a10.23736/S1824-4785.18.03090-X$$n3$$p267-71$$tThe quarterly journal of nuclear medicine and molecular imaging$$v62$$x0392-0208$$y2018
000845495 8564_ $$uhttps://juser.fz-juelich.de/record/845495/files/R39Y2018N03A0267.pdf$$yRestricted
000845495 8564_ $$uhttps://juser.fz-juelich.de/record/845495/files/R39Y2018N03A0267.pdf?subformat=pdfa$$xpdfa$$yRestricted
000845495 909CO $$ooai:juser.fz-juelich.de:845495$$pVDB
000845495 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b4$$kFZJ
000845495 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000845495 9141_ $$y2018
000845495 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000845495 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000845495 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000845495 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000845495 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000845495 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000845495 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000845495 920__ $$lyes
000845495 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000845495 980__ $$ajournal
000845495 980__ $$aVDB
000845495 980__ $$aI:(DE-Juel1)INM-3-20090406
000845495 980__ $$aUNRESTRICTED